A Systematic Review and Statistical Analysis of Factors Influencing the Cost-Effectiveness of Transcatheter Aortic Valve Implantation for Symptomatic Severe Aortic Stenosis
暂无分享,去创建一个
[1] U. Permsuwan,et al. Transcatheter aortic valve implantation in patients with severe symptomatic aortic valve stenosis: systematic review of cost-effectiveness analysis , 2022, The European Journal of Health Economics.
[2] G. de Pouvourville,et al. Cost-Effectiveness Analysis of SAPIEN 3 Transcatheter Aortic Valve Implantation Procedure Compared With Surgery in Patients With Severe Aortic Stenosis at Low Risk of Surgical Mortality in France. , 2021, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[3] B. Prendergast,et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. , 2021, European heart journal.
[4] B. Prendergast,et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. , 2021, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[5] C. Young,et al. Transcatheter Aortic Valve Implantation for Patients with Severe Symptomatic Aortic Stenosis , 2021, Canadian Journal of Health Technologies.
[6] A. Keech,et al. Transcatheter Aortic Valve Implantation (TAVI) Versus Surgical Aortic Valve Replacement for Aortic Stenosis (SAVR): A Cost-Comparison Study. , 2021, Heart, lung & circulation.
[7] V. Lorenzoni,et al. The cost-effectiveness of transcatheter aortic valve implantation: exploring the Italian National Health System perspective and different patient risk groups , 2021, The European Journal of Health Economics.
[8] D. Pascual,et al. Cost-effectiveness analysis of the SAPIEN 3 transcatheter aortic valve implant in patients with symptomatic severe aortic stenosis. , 2021, Revista espanola de cardiologia.
[9] Astrid E. Berggreen,et al. Impact of Anesthesia Strategy and Valve Type on Clinical Outcomes After Transcatheter Aortic Valve Replacement. , 2021, Journal of the American College of Cardiology.
[10] M. Mack,et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2020, Circulation.
[11] M. Mack,et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2020, Journal of the American College of Cardiology.
[12] H. Thiele,et al. Paravalvular Regurgitation According to Transcatheter Aortic Valve Prosthesis Type: Insights From the Randomized SOLVE-TAVI Trial. , 2020, JACC. Cardiovascular imaging.
[13] D. Stub,et al. Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients With Severe Aortic Stenosis. , 2020, Heart, lung & circulation.
[14] G. Shields,et al. Challenges in synthesising cost-effectiveness estimates , 2020, Systematic Reviews.
[15] H. Wijeysundera,et al. The cost-effectiveness of transcatheter aortic valve replacement in low surgical risk patients with severe aortic stenosis. , 2020, European heart journal. Quality of care & clinical outcomes.
[16] K. Poh,et al. Cost-Effectiveness of Transcatheter Aortic Valve Implantation in Intermediate and Low Risk Severe Aortic Stenosis Patients in Singapore. , 2020, Annals of the Academy of Medicine, Singapore.
[17] S. Kapadia,et al. Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial , 2020, The Lancet.
[18] K. Nakao,et al. Cost-Effectiveness of Transcatheter Aortic Valve Implantation Using a Balloon-Expandable Valve in Japan: Experience From the Japanese Pilot Health Technology Assessment. , 2020, Value in health regional issues.
[19] I. König,et al. Comparison of newer generation self-expandable vs. balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial. , 2020, European heart journal.
[20] L. Søndergaard,et al. Cost-Effectiveness of Transcatheter versus Surgical Aortic Valve Replacement inPatients at Lower Surgical Risk: Results from the NOTION Trial. , 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[21] M. Mack,et al. Cost-Effectiveness of Transcatheter Mitral Valve Repair versus Medical Therapy in Patients with Heart Failure and Secondary Mitral Regurgitation: Results from the COAPT Trial. , 2019, Circulation.
[22] B. Prendergast,et al. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial , 2019, The Lancet.
[23] D. Stub,et al. Cost-effectiveness of transcatheter aortic valve implantation compared to surgical aortic valve replacement in the intermediate surgical risk population. , 2019, International journal of cardiology.
[24] N. Burke,et al. A Canadian cost-effectiveness analysis of SAPIEN 3 transcatheter aortic valve implantation compared with surgery, in intermediate and high-risk severe aortic stenosis patients , 2019, ClinicoEconomics and outcomes research : CEOR.
[25] J. Leipsic,et al. Transcatheter Aortic‐Valve Replacement with a Balloon‐Expandable Valve in Low‐Risk Patients , 2019, The New England journal of medicine.
[26] Andrew S. Mugglin,et al. Transcatheter Aortic‐Valve Replacement with a Self‐Expanding Valve in Low‐Risk Patients , 2019, The New England journal of medicine.
[27] M. Mack,et al. Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk: Results From the PARTNER 2 Trial , 2019, Circulation.
[28] G. de Pouvourville,et al. Cost-effectiveness analysis of the SAPIEN 3 TAVI valve compared with surgery in intermediate-risk patients , 2019, Journal of medical economics.
[29] H. Wijeysundera,et al. Cost-Effectiveness of Self-Expandable Transcatheter Aortic Valves in Intermediate-Risk Patients. , 2018, The Annals of thoracic surgery.
[30] B. Carabello,et al. Aortic stenosis , 2018, Rapid Cardiac Care.
[31] F. Petracca,et al. Access Sites for TAVI: Patient Selection Criteria, Technical Aspects, and Outcomes , 2018, Front. Cardiovasc. Med..
[32] P. Coyte,et al. A cost‐utility analysis of transcatheter versus surgical aortic valve replacement for the treatment of aortic stenosis in the population with intermediate surgical risk , 2018, The Journal of thoracic and cardiovascular surgery.
[33] N. Maniadakis,et al. Systematic review of the cost-effectiveness of transcatheter interventions for valvular heart disease , 2018, European heart journal. Quality of care & clinical outcomes.
[34] I. Komuro,et al. Cost effectiveness of transcatheter aortic valve implantation in patients with aortic stenosis in Japan. , 2017, Journal of cardiology.
[35] A. Kappetein,et al. Cost-Effectiveness and Projected Survival of Self-Expanding Transcatheter Versus Surgical Aortic Valve Replacement for High Risk Patients in a European Setting: A Dutch Analysis Based on the CoreValve High Risk Trial , 2017 .
[36] P. Leprince,et al. Temporal Trends in Transcatheter Aortic Valve Replacement in France: FRANCE 2 to FRANCE TAVI. , 2017, Journal of the American College of Cardiology.
[37] Andrew S. Mugglin,et al. Surgical or Transcatheter Aortic‐Valve Replacement in Intermediate‐Risk Patients , 2017, The New England journal of medicine.
[38] Sheldon Goldberg,et al. Aortic Stenosis: Pathophysiology, Diagnosis, and Therapy. , 2017, The American journal of medicine.
[39] M. Branny,et al. Alternative access routes for transcatheter aortic valve implantation (TAVI) , 2017 .
[40] M. Leon,et al. Medical Treatment of Aortic Stenosis , 2016, Circulation.
[41] D. Cohen,et al. Economic Implications of Transcatheter Aortic Valve Replacement in Patients at Intermediate Surgical Risk. , 2016, Circulation.
[42] J. Leipsic,et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis , 2016, The Lancet.
[43] M. Mack,et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. , 2016, The New England journal of medicine.
[44] D. Adams,et al. Cost-Effectiveness of Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis Versus Surgical Aortic Valve Replacement. , 2016, Journal of the American College of Cardiology.
[45] M. Sculpher,et al. Cost-utility of transcatheter aortic valve implantation for inoperable patients with severe aortic stenosis treated by medical management: a UK cost-utility analysis based on patient-level data from the ADVANCE study , 2014, Open Heart.
[46] P. Indraratna,et al. Systematic review of the cost-effectiveness of transcatheter aortic valve implantation. , 2014, The Journal of thoracic and cardiovascular surgery.
[47] Peter Jüni,et al. Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. , 2014, Journal of the American College of Cardiology.
[48] N. Moat,et al. Is transcatheter aortic valve implantation (TAVI) a cost-effective treatment in patients who are ineligible for surgical aortic valve replacement? A systematic review of economic evaluations , 2014, Journal of medical economics.
[49] S. Bayliss,et al. Cost-effectiveness of transcatheter aortic valve implantation (TAVI) for aortic stenosis in patients who are high risk or contraindicated for surgery: a model-based economic evaluation. , 2013, Health technology assessment.
[50] R. Goeree,et al. Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective. , 2013, The Journal of thoracic and cardiovascular surgery.
[51] D. Owens,et al. Transcatheter Aortic Valve Replacement in Nonsurgical Candidates With Severe, Symptomatic Aortic Stenosis: A Cost-Effectiveness Analysis , 2013, Circulation. Cardiovascular quality and outcomes.
[52] S. Plein,et al. The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk , 2013, Heart.
[53] J. Webb,et al. Cost effectiveness of transcatheter aortic valve replacement compared to medical management in inoperable patients with severe aortic stenosis: Canadian analysis based on the PARTNER Trial Cohort B findings , 2013, Journal of medical economics.
[54] W. Toff,et al. TRANSCATHETER AORTIC VALVE IMPLANTATION FOR SEVERE AORTIC STENOSIS: THE COST-EFFECTIVENESS CASE FOR INOPERABLE PATIENTS IN THE UNITED KINGDOM , 2013, International Journal of Technology Assessment in Health Care.
[55] M. Mack,et al. Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). , 2012, Journal of the American College of Cardiology.
[56] M. Dweck,et al. Calcific aortic stenosis: a disease of the valve and the myocardium. , 2012, Journal of the American College of Cardiology.
[57] Jennifer Taylor,et al. ESC/EACTS Guidelines on the management of valvular heart disease. , 2012, European heart journal.
[58] Alain Cribier,et al. Transcatheter aortic valve implantation 10-year anniversary: review of current evidence and clinical implications. , 2012, European heart journal.
[59] E. Tuzcu,et al. Markov model for selection of aortic valve replacement versus transcatheter aortic valve implantation (without replacement) in high-risk patients. , 2012, The American journal of cardiology.
[60] T. Marwick,et al. Perspective on the cost-effectiveness of transapical aortic valve implantation in high-risk patients: Outcomes of a decision-analytic model. , 2012, Annals of cardiothoracic surgery.
[61] Alain Cribier,et al. Development of transcatheter aortic valve implantation (TAVI): a 20-year odyssey. , 2012, Archives of cardiovascular diseases.
[62] W. O’Neill,et al. Cost-Effectiveness of Transcatheter Aortic Valve Replacement Compared With Standard Care Among Inoperable Patients With Severe Aortic Stenosis: Results From the Placement of Aortic Transcatheter Valves (PARTNER) Trial (Cohort B) , 2012, Circulation.
[63] S. Palmer,et al. Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement , 2011, Heart.
[64] E. Bates. Treatment Options in Severe Aortic Stenosis , 2011, Circulation.
[65] Stuart J Pocock,et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. , 2011, The New England journal of medicine.
[66] S. Pocock,et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. , 2010, The New England journal of medicine.
[67] M. Forsting,et al. Silent and Apparent Cerebral Ischemia After Percutaneous Transfemoral Aortic Valve Implantation: A Diffusion-Weighted Magnetic Resonance Imaging Study , 2010, Circulation.
[68] Eric R. Ziegel,et al. The Elements of Statistical Learning , 2003, Technometrics.
[69] Assaf Bash,et al. Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis: First Human Case Description , 2002, Circulation.
[70] O. Hess,et al. Spontaneous course of aortic valve disease. , 1987, European heart journal.
[71] Franz Schwarz,et al. The Effect of Aortic Valve Replacement on Survival , 1982, Circulation.
[73] N. Sikich,et al. Transcatheter Aortic Valve Implantation for Treatment of Aortic Valve Stenosis: A Health Technology Assessment. , 2016, Ontario health technology assessment series.
[74] C. Roobottom,et al. Transcatheter aortic valve insertion (TAVI): a review. , 2014, The British journal of radiology.
[75] B. Ramlawi,et al. Surgical Approaches to Aortic Valve Replacement and Repair-Insights and Challenges. , 2014, Interventional cardiology.
[76] R. Goeree,et al. Transcatheter aortic valve implantation (TAVI) for treatment of aortic valve stenosis: an evidence-based Analysis (part B). , 2012, Ontario health technology assessment series.
[77] M. Mack,et al. Transapical minimally invasive aortic valve implantation , 2007 .